Abstract

Butterbur (Petasites japonicus (Siebold & Zucc.) Maxim) leaves are available to consumers in the marketplace, but there is no guarantee that they are safe for human consumption. Previously, we demonstrated that hot water extracts of P. japonicus leaves (KP-1) had anti-inflammatory properties and attenuated memory impairment. However, data regarding KP-1 toxicity are lacking. This study assessed the safety of KP-1 by examining oral and genotoxic effects using in vivo and in vitro tests, respectively. In a single oral dose toxicity and two-week repeated oral dose toxicity study, we observed no toxicologically significant clinical signs or changes in hematology, blood chemistry, and organ weights at any dose during the experiment. Following a thirteen-week repeated oral dose, toxicity, hyperkeratosis, and squamous cell hyperplasia of the limiting ridge in the stomach were observed. The no observable adverse effect level (NOAEL) was found to be 1250 mg/kg/day in male and female rats. However, hyperkeratosis and hyperplasia were not considered to be of toxicological significance when extrapolating the NOAEL to humans because the limiting ridge in the stomach is species-specific to rats. Therefore, in our study, the NOAEL was considered to be 5000 mg/kg/day when the changes in the stomach’s limiting ridge were discounted. Moreover, in vitro bacterial reverse mutations and chromosomal aberrations in Chinese hamster lung (CHL) cells and the in vivo micronucleus in Institute of cancer research (ICR) mice assays showed that KP-1 possessed no mutagenicity. Although additional research is required, these toxicological evaluations suggest that KP-1 could be safe for human consumption.

Highlights

  • Butterbur (Petasites japonicus (Siebold & Zucc.) Maxim) is a herb in the family of Asteraceae, which is distributed in East Asia [1]

  • Validation of the KP-1 extraction method by high-performance liquid chromatography (HPLC), in vivo single and repeated oral dose toxicity tests, and in vitro genotoxicity tests were performed to assess the safety of KP-1

  • Based on the results of this study, the no observed adverse effect level (NOAEL) of KP-1 was considered to be less than 1250 mg/kg/day in males and to be 1250 mg/kg/day in female rats after repeated oral administration for thirteen weeks under the conditions of this study

Read more

Summary

Introduction

Butterbur (Petasites japonicus (Siebold & Zucc.) Maxim) is a herb in the family of Asteraceae, which is distributed in East Asia [1]. P. japonicus leaf (PL) inhibits allergies, obesity, and asthma, which are associated with chronic inflammatory diseases [5] This anti-inflammatory effect of PL is associated with various types of phenolic compounds, such as fukinolic acid, petasinophenol, phenylprophenoyl, and sulfonic acid, which inhibit free radical scavenging and nitric oxide (NO) production in macrophages [6,7]. The present study was designed to obtain safety data by validating an analytical method for standardization and evaluating the in vivo single and repeated oral dose toxicity and in vitro genotoxicity of KP-1. This will be the basis for the future recognition of Butterbur as a health-functional food

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call